STOCKHOLM, Aug. 16, 2021 /PRNewswire/ -- Medicover has
acquired the Norwegian Fertility company Klinikk Hausken and
acquired 70 per cent of the voting rights for 18.2 MEUR
including assumed debt. Revenue for 2020 amounted to 6.5 MEUR.
Klinikk Hausken is Norway's
leading private IVF group and consist of four clinics performing
over 2,800 cycles per annum, with the Oslo facility being Norway's largest private in-vitro clinic.
"Klinikk Hausken is a very well managed company and a good fit
to our fertility network and given the liberalisation of the
Norwegian IVF legalisation the market is expected to grow
significantly ahead. The acquisition is a good foundation for
further expansion in Norway," says
James Barr, Managing Director of
Fertility Services, Medicover.
For further information, please contact:
Hanna Bjellquist, Head of
Investor Relations
Tel.:+46 703 033 272
Email: hanna.bjellquist@medicover.com
The information was provided for publication by the
abovementioned contact person at 15.00 CEST on
16 August 2021.
About Medicover:
Medicover is a leading international healthcare and
diagnostic services company and was founded in 1995. Medicover
operates a large number of ambulatory clinics, hospitals,
specialty-care facilities,laboratories and blood-drawing
points and the largest markets are Poland and Germany. In 2020, Medicover had revenue of
EUR 998 million and more than 32,000
employees. For more information, go to
www.medicover.com
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/medicover/r/medicover-is-expanding-its-fertility-network-into-norway,c3396876
The following files are available for download:
|
https://mb.cision.com/Main/15662/3396876/1454428.pdf
|
Medicover is
expanding its fertility network into Norway
|